These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26692196)

  • 41. [Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment].
    Kuzmina LA; Petinati NA; Vasilieva VA; Dovydenko MV; Drokov MY; Davydova YO; Kapranov NM; Sats NV; Chabaeva YA; Kulikov SM; Gaponova TV; Drize NI; Parovichnikova EN; Savchenko VG
    Ter Arkh; 2020 Sep; 92(7):23-30. PubMed ID: 33346442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mesenchymal stromal/stem cell therapy for acute graft versus host disease: the next step].
    Miura Y; Fujii S
    Rinsho Ketsueki; 2020; 61(8):953-958. PubMed ID: 32908060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
    Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation.
    Stenger EO; Krishnamurti L; Galipeau J
    BMC Immunol; 2015 Dec; 16():74. PubMed ID: 26674007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ressarch Advances of Prevantive and Therapeatic Effect of Mesenchymal Stromal Cells on Graft-Versus-Host Disease--Review].
    Wang L; Ma DX; Liu SF; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):283-287. PubMed ID: 30738484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Research Advance on Role of Umbilical Cord Mesenchymal Stem Cell in Hematopoietic Stem Cells Transplantation-Review].
    Qiao SM; Wang Y; Song XL; Yue YN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1847-1850. PubMed ID: 29262929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunomodulation of bone marrow mesenchymal stem cells in hematopoietic stem cell transplantation--review].
    Gao L; Wang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):907-10. PubMed ID: 16277869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal Stromal Cells Stimulate the Proliferation and IL-22 Production of Group 3 Innate Lymphoid Cells.
    van Hoeven V; Munneke JM; Cornelissen AS; Omar SZ; Spruit MJ; Kleijer M; Bernink JH; Blom B; Voermans C; Hazenberg MD
    J Immunol; 2018 Aug; 201(4):1165-1173. PubMed ID: 29980610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis.
    Chen W; Li M; Su G; Zang Y; Yan Z; Cheng H; Pan B; Cao J; Wu Q; Zhao K; Zhu F; Zeng L; Li Z; Xu K
    Cell Biochem Biophys; 2015 Apr; 71(3):1579-87. PubMed ID: 25391891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal stromal cells in hematopoietic cell transplantation.
    Burnham AJ; Daley-Bauer LP; Horwitz EM
    Blood Adv; 2020 Nov; 4(22):5877-5887. PubMed ID: 33232479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis.
    Hashmi S; Ahmed M; Murad MH; Litzow MR; Adams RH; Ball LM; Prasad VK; Kebriaei P; Ringden O
    Lancet Haematol; 2016 Jan; 3(1):e45-52. PubMed ID: 26765648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Trials With Mesenchymal Stem Cells: An Update.
    Squillaro T; Peluso G; Galderisi U
    Cell Transplant; 2016; 25(5):829-48. PubMed ID: 26423725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease.
    Fan X; Gay FP; Ong SY; Ang JM; Chu PP; Bari S; Lim TK; Hwang WY
    Cytotherapy; 2013 May; 15(5):610-9. PubMed ID: 23419678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early osteoinductive human bone marrow mesenchymal stromal/stem cells support an enhanced hematopoietic cell expansion with altered chemotaxis- and adhesion-related gene expression profiles.
    Sugino N; Miura Y; Yao H; Iwasa M; Fujishiro A; Fujii S; Hirai H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Biochem Biophys Res Commun; 2016 Jan; 469(4):823-9. PubMed ID: 26707642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
    Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
    Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.
    Kebriaei P; Isola L; Bahceci E; Holland K; Rowley S; McGuirk J; Devetten M; Jansen J; Herzig R; Schuster M; Monroy R; Uberti J
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):804-11. PubMed ID: 19539211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses.
    Reddy BY; Xu DS; Hantash BM
    Stem Cells Dev; 2012 Feb; 21(3):352-62. PubMed ID: 21864110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
    Lucchini G; Introna M; Dander E; Rovelli A; Balduzzi A; Bonanomi S; Salvadè A; Capelli C; Belotti D; Gaipa G; Perseghin P; Vinci P; Lanino E; Chiusolo P; Orofino MG; Marktel S; Golay J; Rambaldi A; Biondi A; D'Amico G; Biagi E
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1293-301. PubMed ID: 20350611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental therapy of graft-versus-host disease by mesenchymal stromal cells grown on oxide nanocoatings.
    Goltsev AN; Rassokha IV; Dubrava TG; Ostankova LV; Ostankov MV; Safonov VI; Zykova AV
    Fiziol Zh (1994); 2016; 62(5):3-11. PubMed ID: 30204336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.